Login / Signup

Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma.

Andrea M JohnsonJeanne M DudekDavid K Edwards VTheran A MyersPatrick JosephJennifer J LaffinJanelle J Bruinsma
Published in: Expert review of molecular diagnostics (2021)
These data demonstrate that the mt-HBT can produce consistent, reliable results for patients in the intended-use population, for whom surveillance is recommended.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • public health
  • peritoneal dialysis
  • prognostic factors
  • electronic health record
  • big data
  • patient reported outcomes
  • data analysis